Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring

Open access

Abstract

AIMS: Despite the wide use of metformin in metabolically challenged pregnancies, the long-term effects on the metabolism of the offspring are not known. We studied the long-term effects of prenatal metformin exposure during metabolically challenged pregnancy in mice. MATERIALS AND METHODS: Female mice were on a high fat diet (HFD) prior to and during the gestation. Metformin was administered during gestation from E0.5 to E17.5. Male and female offspring were weaned to a regular diet (RD) and subjected to HFD at adulthood (10-11 weeks). Body weight and several metabolic parameters (e.g. body composition and glucose tolerance) were measured during the study. Microarray and subsequent pathway analyses on the liver and subcutaneous adipose tissue of the male offspring were performed at postnatal day 4 in a separate experiment. RESULTS: Prenatal metformin exposure changed the offspring's response to HFD. Metformin exposed offspring gained less body weight and adipose tissue during the HFD phase. Additionally, prenatal metformin exposure prevented HFD-induced impairment in glucose tolerance. Microarray and annotation analyses revealed metformin-induced changes in several metabolic pathways from which electron transport chain (ETC) was prominently affected both in the neonatal liver and adipose tissue. CONCLUSION: This study shows the beneficial effects of prenatal metformin exposure on the offspring's glucose tolerance and fat mass accumulation during HFD. The transcriptome data obtained at neonatal age indicates major effects on the genes involved in mitochondrial ATP production and adipocyte differentiation suggesting the mechanistic routes to improved metabolic phenotype at adulthood.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0115778

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study design. Female mice were fed with HFD prior to (weeks −7– −3) and during the gestation. Metformin was administered from E0.5 to 17.5. Week 0 denotes the birth of the offspring. The data were obtained from two separate set of mice, study I and II as indicated below the timeline. Study I: gestational glucose measurement, microarray samples and a surrogate group until E18.5; Study II: the long-term follow of the offspring and a surrogate group until E18.5. Only male offspring were used for the microarray analyses. At the end of the study, the offspring in the long-term study II were subjected to an acute metformin administration (2×300 mg/kg). Dotted areas = periods of food intake measurement. GTT = glucose tolerance test.
Figure 1 Study design. Female mice were fed with HFD prior to (weeks −7– −3) and during the gestation. Metformin was administered from E0.5 to 17.5. Week 0 denotes the birth of the offspring. The data were obtained from two separate set of mice, study I and II as indicated below the timeline. Study I: gestational glucose measurement, microarray samples and a surrogate group until E18.5; Study II: the long-term follow of the offspring and a surrogate group until E18.5. Only male offspring were used for the microarray analyses. At the end of the study, the offspring in the long-term study II were subjected to an acute metformin administration (2×300 mg/kg). Dotted areas = periods of food intake measurement. GTT = glucose tolerance test.CC BY · PubMed Central
Figure 2 The effect of HFD and metformin treatment on the metabolism of the dams. Body weight during pre-gestational HFD period (A). Fasting blood glucose after three weeks of HFD consumption (B). Body weight development during E0.5–17.5 (C). Blood glucose on the second week (E11.5–12.5) of the gestation (D). * = P<0.05 by Student's t-test.
Figure 2 The effect of HFD and metformin treatment on the metabolism of the dams. Body weight during pre-gestational HFD period (A). Fasting blood glucose after three weeks of HFD consumption (B). Body weight development during E0.5–17.5 (C). Blood glucose on the second week (E11.5–12.5) of the gestation (D). * = P<0.05 by Student's t-test.CC BY · PubMed Central
Figure 3 Weight of the fetuses (E18.5). Body weight of litters at E18.5; ctr1-4 denotes prenatal control litters and met1-4 prenatal metformin litters, Litter size 8–9. ** = P<0.01 by Mann-Whitney test when individual fetal weights are tested (pooled results from two separate studies).
Figure 3 Weight of the fetuses (E18.5). Body weight of litters at E18.5; ctr1-4 denotes prenatal control litters and met1-4 prenatal metformin litters, Litter size 8–9. ** = P<0.01 by Mann-Whitney test when individual fetal weights are tested (pooled results from two separate studies).CC BY · PubMed Central
Figure 4 The effect of prenatal metformin exposure on the body weight of the offspring during RD and HFD phases. Female (A) and male offspring (B) during RD and HFD. Black circles (•) = Control offspring, open circles (○) = Metformin offspring. * = P<0.05 by 2-way RM-ANOVA and Sidak's multiple comparisons test. The body weight change during the HFD in the female (C) and male (D) offspring. n = 13–16, * = P<0.05 by Mann-Whitney test.
Figure 4 The effect of prenatal metformin exposure on the body weight of the offspring during RD and HFD phases. Female (A) and male offspring (B) during RD and HFD. Black circles (•) = Control offspring, open circles (○) = Metformin offspring. * = P<0.05 by 2-way RM-ANOVA and Sidak's multiple comparisons test. The body weight change during the HFD in the female (C) and male (D) offspring. n = 13–16, * = P<0.05 by Mann-Whitney test.CC BY · PubMed Central
Figure 5 Adipocyte size distribution in gWAT at the end of the postnatal HFD phase. The percentage of the adipocytes on every 500 µm2. * = P<0.05, ** = P<0.01 and *** = P<0.001 by 2-way ANOVA and Sidak's multiple comparisons test (A). AUC of the adipocyte size distribution curve ≤3000 µm2 and ≥ 3000 µm2 (B). Relative amount of adipocytes (C). n = 11–14. * = P<0.05 by Student's t-test.
Figure 5 Adipocyte size distribution in gWAT at the end of the postnatal HFD phase. The percentage of the adipocytes on every 500 µm2. * = P<0.05, ** = P<0.01 and *** = P<0.001 by 2-way ANOVA and Sidak's multiple comparisons test (A). AUC of the adipocyte size distribution curve ≤3000 µm2 and ≥ 3000 µm2 (B). Relative amount of adipocytes (C). n = 11–14. * = P<0.05 by Student's t-test.CC BY · PubMed Central
Figure 6 Glucose tolerance of the offspring during RD and HFD. GTT of the female (A) and male offspring (B) at 10 weeks of age during RD and after 5–6 weeks of HFD. Black circles (•) = Control offspring on RD, open circles (○) = Metformin offspring on RD, Black triangles (▴) = Control offspring on HFD, open triangles (Δ) = Metformin offspring on HFD. n = 12–16. AUC values of the GTT of the female (C) and male (D) offspring. ** = P<0.01 and *** = P<0.001 by 2-way RM-ANOVA and Sidak's multiple comparisons test. P-value of interaction 0.063 in C and <0.05 in D.
Figure 6 Glucose tolerance of the offspring during RD and HFD. GTT of the female (A) and male offspring (B) at 10 weeks of age during RD and after 5–6 weeks of HFD. Black circles (•) = Control offspring on RD, open circles (○) = Metformin offspring on RD, Black triangles (▴) = Control offspring on HFD, open triangles (Δ) = Metformin offspring on HFD. n = 12–16. AUC values of the GTT of the female (C) and male (D) offspring. ** = P<0.01 and *** = P<0.001 by 2-way RM-ANOVA and Sidak's multiple comparisons test. P-value of interaction 0.063 in C and <0.05 in D.CC BY · PubMed Central
Figure 7 Heatmaps of the liver and SAT gene expression. Hepatic gene expression profile of vehicle and metformin exposed male offspring at the age of 4 days, n = 6 in both groups. Genes with adjusted P-value <0.05 and LogFC cut-off ≥0.5 are shown (A). SAT gene expression profile of vehicle and metformin exposed male offspring at the age of 4 days, n = 6 in the control offspring, n = 5 in the metformin offspring. Genes with adjusted P-value <0.01 and LogFC cut-off ≥1 are shown (B).
Figure 7 Heatmaps of the liver and SAT gene expression. Hepatic gene expression profile of vehicle and metformin exposed male offspring at the age of 4 days, n = 6 in both groups. Genes with adjusted P-value <0.05 and LogFC cut-off ≥0.5 are shown (A). SAT gene expression profile of vehicle and metformin exposed male offspring at the age of 4 days, n = 6 in the control offspring, n = 5 in the metformin offspring. Genes with adjusted P-value <0.01 and LogFC cut-off ≥1 are shown (B).CC BY · PubMed Central
Figure 8 Prenatal metformin exposure in neonatal TCA and ETC pathways. Differentially (P<0.05) expressed genes in TCA cycle and ETC in the liver (A–B) and SAT (C–D) in response to prenatal metformin exposure are shown coloured.
Figure 8 Prenatal metformin exposure in neonatal TCA and ETC pathways. Differentially (P<0.05) expressed genes in TCA cycle and ETC in the liver (A–B) and SAT (C–D) in response to prenatal metformin exposure are shown coloured.CC BY · PubMed Central
Figure 9 qPCR validation on the microarray-based gene expression profile in the neonatal liver and SAT. The expression of Fh1 (fumarate hydratase 1), Ndufs4 (NADH dehydrogenase (ubiquinone) Fe-S protein 4), Etfdh (electron transferring flavoprotein, dehydrogenase), Uqcrh (ubiquinol-cytochrome c reductase hinge protein), Atp5c1 (ATP synthase, H+transporting, mitochondrial F1 complex, gamma polypeptide 1), Ivd (isovaleryl coenzyme A dehydrogenase) and Acaa2 (acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)) in the neonatal liver (A) by qPCR. n = 6 in both groups. * = P<0.05, ** = P<0.01 and *** = P<0.001. The expression of Ucp1 (uncoupling protein 1), Cidea (cell death-inducing DNA fragmentation factor, alpha subunit-like effector A), Cpt1b (carnitine palmitoyltransferase 1b) (B), Ndufs4 (NADH dehydrogenase (ubiquinone) Fe-S protein 4), Etfdh (electron transferring flavoprotein, dehydrogenase), Cox7b (cytochrome c oxidase subunit VIIb), Cycs (cytochrome c), Ivd (isovaleryl coenzyme A dehydrogenase), AdipoQ (adiponectin), Acaa2 (acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)) and Ces3 (carboxylesterase 1D) in the neonatal SAT (C) by qPCR. n = 5 in Met and 6 in Ctr group. * = P<0.05 and *** = P<0.001 by Student's t-test or Mann-Whitney test. Ucp1, Cidea and Cpt1b presented separately due to a different scale in the expression levels.
Figure 9 qPCR validation on the microarray-based gene expression profile in the neonatal liver and SAT. The expression of Fh1 (fumarate hydratase 1), Ndufs4 (NADH dehydrogenase (ubiquinone) Fe-S protein 4), Etfdh (electron transferring flavoprotein, dehydrogenase), Uqcrh (ubiquinol-cytochrome c reductase hinge protein), Atp5c1 (ATP synthase, H+transporting, mitochondrial F1 complex, gamma polypeptide 1), Ivd (isovaleryl coenzyme A dehydrogenase) and Acaa2 (acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)) in the neonatal liver (A) by qPCR. n = 6 in both groups. * = P<0.05, ** = P<0.01 and *** = P<0.001. The expression of Ucp1 (uncoupling protein 1), Cidea (cell death-inducing DNA fragmentation factor, alpha subunit-like effector A), Cpt1b (carnitine palmitoyltransferase 1b) (B), Ndufs4 (NADH dehydrogenase (ubiquinone) Fe-S protein 4), Etfdh (electron transferring flavoprotein, dehydrogenase), Cox7b (cytochrome c oxidase subunit VIIb), Cycs (cytochrome c), Ivd (isovaleryl coenzyme A dehydrogenase), AdipoQ (adiponectin), Acaa2 (acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)) and Ces3 (carboxylesterase 1D) in the neonatal SAT (C) by qPCR. n = 5 in Met and 6 in Ctr group. * = P<0.05 and *** = P<0.001 by Student's t-test or Mann-Whitney test. Ucp1, Cidea and Cpt1b presented separately due to a different scale in the expression levels.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 67

Metadata

Authors
Salomäki, H., Heinäniemi, M., Vähätalo, L. H., Ailanen, L., Eerola, K., Ruohonen, S. T., Pesonen, U., & Koulu, M.
Affiliations
  • University of Turku (FI)
  • University of Eastern Finland (FI)
Corresponding author
Koulu, Markku
Venue
PLoS ONE
Published
2014-12-26
Volume
9
Issue
12
Pages
e115778
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1997868883
Cited by
63
References
53
Citations by year
2026: 2 · 2025: 7 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 9 · 2020: 3 · 2019: 2 · 2018: 13 · 2017: 5 · 2016: 6 · 2015: 2
FWCI
4.07
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Helsingin Yliopisto
  • Kela
  • Academy of Finland
  • Turun Yliopisto
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
maternal high-fat diet, fat mass accumulation, electron transport chain, mitochondrial ATP production, adipogenesis
MeSH terms
Animals, Blood Glucose, Body Weight, Female, Fetus, Glucose Tolerance Test, Lipids, Liver, Male, Metformin, Mice, Inbred C57BL, Pregnancy, Prenatal Exposure Delayed Effects, Adipocytes, Cell Size, Mice, Adipose Tissue, White, Adipokines, Diet, High-Fat, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring. https://app.cochat.ai/papers/10.1371/journal.pone.0115778
The paper
Salomäki, H., Heinäniemi, M., Vähätalo, L. H., Ailanen, L., Eerola, K., Ruohonen, S. T., Pesonen, U., & Koulu, M. (2014). Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring. PLoS ONE. https://doi.org/10.1371/journal.pone.0115778

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.